Help Prevent Medication Errors Français
A component of the Canadian Medication Incident Reporting and Prevention System (CMIRPS).

SafeMedicationUse Newsletter

Health Canada Endorsed Important Safety Information on Pradax (dabigatran) and Plavix (clopidogrel)


Boehringer Ingelheim (Canada) Ltd. and Sanofi-aventis Canada Inc., in consultation with Health Canada, are alerting consumers to the risk of medication errors associated with name confusion between the anticoagulant Pradax and the antiplatelet drug Plavix.

More information is available on the Health Canada website.

Read the previous alert Beware of Potential Confusion Between Pradax and Plavix.

facbook twitter
About Us | Contact Us | Disclaimer | Privacy
Copyright © 2023 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved.